|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Investments, at fair value | |||||||||||||||||
| Non-controlled/non-affiliated | |||||||||||||||||
| Non-controlled/affiliated | |||||||||||||||||
| Controlled/affiliated | |||||||||||||||||
| Total investments, at fair value | |||||||||||||||||
| Cash, cash equivalents and restricted cash | |||||||||||||||||
| Receivable for investments sold | |||||||||||||||||
| Deferred financing costs | |||||||||||||||||
| Interest and dividend receivable | |||||||||||||||||
| Derivative assets, at fair value (Note 8) | |||||||||||||||||
| Prepaid expenses and other assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| LIABILITIES | |||||||||||||||||
| Secured borrowings (Note 7) | |||||||||||||||||
| Debt and secured borrowings (Note 9) | |||||||||||||||||
| Payable for investments purchased | |||||||||||||||||
| Interest and credit facility fees payable (Note 9) | |||||||||||||||||
| Dividend payable (Note 11) | |||||||||||||||||
| Base management and incentive fees payable (Note 4) | |||||||||||||||||
| Administrative service fees payable (Note 4) | |||||||||||||||||
| Derivative liabilities, at fair value (Note 8) | |||||||||||||||||
| Other accrued expenses and liabilities | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| NET ASSETS | |||||||||||||||||
| Cumulative convertible preferred stock, $0.01 par value; 0 and 2,000,000 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | |||||||||||||||||
| Common stock, $0.01 par value; 198,000,000 shares authorized; 68,590,231 and 71,807,190 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | |||||||||||||||||
| Paid-in capital in excess of par value | |||||||||||||||||
| Offering costs | |||||||||||||||||
| Total distributable earnings (loss) | |||||||||||||||||
| Total net assets | |||||||||||||||||
| NET ASSETS PER COMMON SHARE (in dollars per share) | |||||||||||||||||
| Preferred stock, par value (in dollars per share) | |||||||||||||||||
| Preferred stock, issued (in shares) | |||||||||||||||||
Loading...